OakChart

Lumexa Imaging Holdings Inc

LMRIHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 3:14 PM ET

15.79+1.87 (13.43%)
2026-11-11 21:15 CET
Market cap
1,337.36 USD m
Revenue, TTM
271.97 USD m
Net income, TTM
7.18 USD m
Free cash flow, TTM
20.60 USD m
EPS diluted, TTM
0.07
P/E
-
Compare

Price

LMRI against its 20, 50 and 200-day averages
2050200miss
7.5010.0012.5015.001.6M3.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26LMRIclose 15.7920-day 12.0150-day 11.33200-day 11.0415.7952w low

18.8% under the 52-week high of 19.45 on 15 Dec 2025. 52-week low 6.45 on 15 May 2026. Last 15 sessions, 56.1% high to low

Volume 1.86× normal · the line is the 50-bar volume average

Profile

LMRI
52-week range, 72% of the way up
6.4519.45

Lumexa Imaging Holdings, Inc. engages in providing diagnostic imaging services. It focuses on its teleradiology platform, Connexia. It operates through the Outpatient Imaging Centers (Outpatient) and Professional Services (Professional) segments. The Outpatient segment performs imaging studies and provides radiologists' interpretations of those studies. The Professional segment relates to the interpretation of imaging studies. The company was founded on November 14, 2025 and is headquartered in NC, Raleigh.

IndexRUT
Employees5019
IPODec 11, 2025
ATR, 14d0.76
Rel volume1.86
Short float7.07%
Insider own73.39%
Inst own35.38%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.52B
Enterprise Value2.40B
Income-17.05M
Sales-
Book/sh6.60
Cash/sh0.94
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees5019
IPODec 11, 2025

Ratios

P/E-
Forward P/E17.34
PEG-
P/S-
P/B2.39
P/C16.85
P/FCF-
EV/EBITDA32.97
EV/Sales-
Quick Ratio1.42
Current Ratio1.52
Debt/Eq1.54
LT Debt/Eq1.47
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.18
EPS next Y0.91
EPS next Q0.22
EPS this Y224.00%
EPS next Y11.24%
EPS next 5Y-
EPS past 3/5Y38.42% -
Sales past 3/5Y4.55% -
EPS Y/Y TTM-
Sales Y/Y TTM-
EPS Q/Q191.76%
Sales Q/Q11.01%
EarningsNov 10 AMC
EPS/Sales Surpr.42.86% 0.63%

Ownership

Insider Own73.39%
Insider Trans0.09%
Inst Own35.38%
Inst Trans5.71%
ROA-
ROE-
ROIC-
Gross Margin-
Oper. Margin-
Profit Margin-
SMA2031.43%
SMA5039.41%
SMA20043.05%
Trades-

Technical

Shs Outstand96.06M
Shs Float25.57M
Short Float7.07%
Short Ratio4.31
Short Interest1.81M
52W High19.45 -18.82%
52W Low6.45 144.81%
Volatility7.20% 4.84%
ATR (14)0.76
RSI (14)85.70
Beta-
Rel Volume1.86
Avg Volume419.51K
Volume692,794

Performance

Perf Week20.53%
Perf Month48.82%
Perf Quarter29.43%
Perf Half Y96.15%
Perf YTD-14.65%
Perf Year-
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.10
Target Price17.89
Prev Close13.92
Price15.79
Change %13.43%

Analyst ratings

latest 10 of 11
DateActionAnalystRating changeTargetImplied
Oct 05, 2026InitiatedTTruistBuy$18+14.0%
Sep 25, 2026InitiatedKKeyBanc Capital MarketsOverweight$18+14.0%
Feb 09, 2026UpgradeRRaymond JamesOutperform → Strong Buy$23+45.7%
Jan 05, 2026InitiatedWWilliam BlairOutperform
Jan 05, 2026InitiatedWWells FargoOverweight$22+39.3%
Jan 05, 2026InitiatedRRaymond JamesOutperform$23+45.7%
Jan 05, 2026InitiatedLLeerink PartnersOutperform$23+45.7%
Jan 05, 2026InitiatedJJP MorganOverweight$23+45.7%
Jan 05, 2026InitiatedJJefferiesBuy$23+45.7%
Jan 05, 2026InitiatedDDeutsche BankBuy$22+39.3%

Peers

Mkt cap
TickerCompanyMkt cap
RDNTRadnet Inc6.15B
SGRYSurgery Partners Inc3.48B
GEHCGE HealthCare Technologies Inc37.41B
AHCOAdaptHealth Corp1.06B
VREXVarex Imaging Corp782.60M
USPHU.S. Physical Therapy Inc1.50B
DGXQuest Diagnostics Inc28.44B
CONConcentra Group Holdings Parent Inc5.47B
LHLabcorp Holdings Inc30.10B
HCAHCA Healthcare Inc104.93B

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
BRODNAX BRETTDirectorMay 19 '26Buy7.2535,000253,75062,027May 21 04:20 PM
Cooper Henry LeeDirectorMay 14 '26Buy7.4430,000223,11330,000May 18 04:12 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
FSMLFranklin Small Cap Enhanced ETFAUM: 150.96M
VHTVanguard Health Care ETFAUM: 21.51B
ONEQFidelity Nasdaq Composite Index ETFAUM: 10.35B
SCHBSchwab U.S. Broad Market ETFAUM: 44.09B

News

latest 14 of 29

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-100.2600.1820.075271.97270.278
2026Q22026-08-120.2000.1480.029264.16263.126
2026Q12026-05-120.1870.1230.018252.54249.527
2025Q42026-03-26-0.3800.046-0.299267.73261.174
2025Q32025-12-03-0.035--0.033260.07--
2026Q4--0.224--280.388
2027Q1--0.187--266.646
2027Q2--0.212--278.566
2027Q3--0.234--285.526
2027Q4--0.271--296.196
2028Q1--0.210--284.591
2028Q2--0.250--296.881
2028Q3--0.300--303.411
2028Q4--0.340--310.281

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY-0.660-0.140-0.6261,0231,016
2026FY-0.818--1,068
2027FY-0.910--1,127
2028FY-1.027--1,189
2029FY-1.197--1,261
2030FY-1.410--1,317

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-11910280.38274.7287.4
2026Q4S2026-11-10910280.56274.7287.4
2026Q4S2026-10-02910280.56274.7287.4
2026Q4S2026-09-25810280.54274.7287.4
2026Q4S2026-09-23800280273.05287.4
2026Q4S2026-09-03700280273.05287.4
2026Q4S2026-08-13700279.85273.05287.4
2026Q4S2026-07-27700279.76272.84287.4
2026Q4S2026-06-30710279.76272.84287.4
2026Q4S2026-06-17720279.76272.84287.4
2026Q4S2026-06-16720279.96274.22287.4
2026Q4S2026-06-09721279.96274.22287.4
2026Q4S2026-05-27731279.96274.22287.4
2026Q4S2026-05-21731280.06274.22287.4

Estimate history

EPS, annual-1.293-0.995-0.49-0.1775
Period202320242025TTM
EPS, quarterly-0.265-0.081-0.2990.0180.0290.075
PeriodQ4 '24Q1 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual935.925948.8691023.081
Period202320242025
Sales, quarterly248.028245.001267.734252.537264.162271.973
PeriodQ4 '24Q1 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual94.56694.56696.1196.062
Period202320242025MRQ
Shares, quarterly94.56694.56696.1196.08196.07596.062
PeriodQ4 '24Q1 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY
Total Revenue271.971,023.08948.87935.92
Cost of Goods Sold Incl. D&A235.90905.89894.77893.59
Gross Profit36.07117.1954.1042.34
Selling, General and Administrative Excl. Other30.0290.4570.3655.16
Other Operating Expense-0.000.000.00
Operating Income6.0526.73-16.26-12.83
Interest Expense15.67118.54136.03141.69
Unusual Expense0.6513.450.7018.97
Net Income Before Taxes11.79-32.22-79.19-119.25
Income Taxes4.6114.8814.912.98
Consolidated Net Income7.18-47.10-94.10-122.23
Net Income From Continuing Operations7.18-47.10-94.10-122.23
Net Income7.18-47.10-94.10-122.23
EPS (Recurring)0.08-0.39-0.99-1.15
EPS (Basic, Before Extraordinaries)0.07-0.49-1.00-1.29
EPS (Diluted)0.07-0.49-1.00-1.29
EBITDA16.3882.5640.8659.24
Non-Operating Income (Expense)22.0773.0473.8054.24
Other After Tax Adjustments-0.000.000.00
Stock Option Compensation Expense9.7532.8744.7643.68
Price To Sales Ratio0.931.74--
Gross Margin-11.455.704.52
Operating Margin-2.61-1.71-1.37
Net Margin--4.60-9.92-13.06
Shares Outstanding96.0696.1194.5794.57
Market Capitalization1,337.361,337.361,730.55-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q12024Q4
Total Revenue271.97264.16252.54267.73245.00248.03
Cost of Goods Sold Incl. D&A235.90234.97227.58238.01216.85236.27
Gross Profit36.0729.1924.9629.7228.1511.76
Selling, General and Administrative Excl. Other30.0219.5716.0537.1912.3920.12
Other Operating Expense-0.000.000.000.000.00
Operating Income6.059.628.91-7.4715.76-8.36
Interest Expense15.6716.2216.3328.0229.8531.39
Unusual Expense0.656.284.3813.455.700.00
Net Income Before Taxes11.795.763.08-25.26-4.31-16.03
Income Taxes4.613.021.363.433.389.03
Consolidated Net Income7.182.751.72-28.69-7.69-25.06
Net Income From Continuing Operations7.182.751.72-28.69-7.69-25.06
Net Income7.182.751.72-28.69-7.69-25.06
EPS (Recurring)0.080.070.05-0.20-0.04-0.26
EPS (Basic, Before Extraordinaries)0.070.030.02-0.30-0.08-0.27
EPS (Diluted)0.070.030.02-0.30-0.08-0.27
EBITDA16.3824.3022.959.2128.665.18
Non-Operating Income (Expense)22.0718.6414.8923.6815.4823.73
Other After Tax Adjustments-0.000.000.000.000.00
Stock Option Compensation Expense9.7510.069.7014.675.0711.09
Price To Sales Ratio0.93-----
Gross Margin13.2611.059.8811.1011.494.74
Operating Margin2.223.643.53-2.796.43-3.37
Net Margin2.641.040.68-10.72-3.14-10.10
Shares Outstanding96.0696.0796.0896.1194.5794.57
Market Capitalization1,337.361,083.79813.261,749.471,730.55-

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY
Cash & Short Term Investments58.8326.1320.19
Short Term Receivables150.85136.00130.25
Inventories0.000.000.00
Other Current Assets16.2810.3916.33
Total Current Assets225.96172.52166.77
Net Property, Plant & Equipment221.26201.93195.81
Total Investments and Advances423.19415.92423.76
Intangible Assets848.89855.34865.93
Deferred Tax Assets48.0941.7541.26
Other Assets45.2524.8619.27
Total Assets1,812.651,712.321,712.79
Short Term Debt Incl. Current Port. of LT Debt38.7835.3237.18
Accounts Payable44.8629.8924.41
Income Tax Payable0.424.040.43
Other Current Liabilities95.14104.4299.08
Total Current Liabilities179.19173.66161.12
Long Term Debt923.731,273.951,267.55
Provision for Risks Charges0.000.000.00
Deferred Tax Liabilities88.8774.4564.20
Other Liabilities34.7428.6121.50
Total Liabilities1,226.531,550.661,514.36
Non-Equity Reserves0.000.000.00
Preferred Stock - Carrying Value0.000.000.00
Common Equity586.12161.65198.43
Total Shareholders Equity586.12161.65198.43
Accumulated Minority Interest0.000.000.00
Total Equity586.12161.65198.43
Total Liabilities & Stockholders Equity1,812.651,712.321,712.79
Book Value Per Share6.101.712.10
Tangible Book Value Per Share-2.73-7.34-7.06
Full-Time Employees5,019--
Price to Book Ratio2.1770.83-
Return on Assets-2.67-5.49-
Return on Equity-12.60-52.27-
Return on Invested Capital-3.12-6.55-8.34
Quick Ratio1.260.991.04
Current Ratio1.260.991.04

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY
Net Income7.18-47.10-94.10-122.23
Depreciation14.8355.8357.1272.07
Other Funds (Non Cash)8.9244.6270.5591.20
Funds from Operations34.3861.4243.3341.65
Extraordinary Item-0.000.000.00
Changes in Working Capital0.43-44.35-2.60-4.14
Cash from Operating Activities34.8117.0740.7337.51
Capital Expenditures-14.21-23.48-27.77-24.01
Net Assets From Acquisitions-0.000.00-3.20
Sale of Fixed Assets and Businesses0.162.645.490.00
Purchase or Sale of Investments0.00-0.120.00-2.45
Purchase of Investments0.00-0.120.00-2.45
Sale Or Maturity of Investments-0.000.000.00
Other Uses-0.000.000.00
Other Sources-0.000.000.00
Cash from Investing Activities-14.05-20.96-22.28-29.66
Cash Dividends Paid-0.000.000.00
Preferred Dividends (Cash Flow)-0.000.000.00
Change in Capital Stock0.00426.970.672.14
Repurchase of Common Pref Stock-0.000.00-0.12
Sale of Common Pref Stock0.00426.970.672.25
Proceedsfrom Stock Options0.00426.970.672.25
Issuance or Reduction of Debt, Net-1.25-392.83-13.17-10.91
Change in Long Term Debt-1.25-392.83-13.17-10.91
Issuance of Long Term Debt6.14823.5440.1023.93
Reduction of Long Term Debt-7.38-1,216.37-53.27-34.84
Net Financing Active Other Cash Flow0.462.430.000.00
Other Financing Activities Uses-0.620.000.000.00
Cash from Financing Activities-0.4536.58-12.50-8.77
Net Change in Cash20.3132.705.95-0.91
Free Cash Flow20.60-6.4012.9513.51
Deferred Taxes & Investment Tax Credit-8.089.750.61

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q12024Q4
Cash & Short Term Investments90.0169.7051.2358.83-26.13
Short Term Receivables173.51172.21154.13150.85-136.00
Inventories-0.000.000.00-0.00
Other Current Assets14.7912.0014.1316.28-10.39
Total Current Assets278.31253.92219.49225.96-172.52
Net Property, Plant & Equipment233.68233.09226.30221.26-201.93
Total Investments and Advances428.02423.33420.52423.19-415.92
Intangible Assets846.14847.28847.80848.89-855.34
Deferred Tax Assets---48.09-41.75
Other Assets46.9951.1549.2445.25-24.86
Total Assets1,833.141,808.771,763.351,812.65-1,712.32
Short Term Debt Incl. Current Port. of LT Debt42.8342.1340.5938.78-35.32
Accounts Payable20.3827.0637.1744.86-29.89
Income Tax Payable-4.230.540.42-4.04
Other Current Liabilities120.24104.9479.6495.14-104.42
Total Current Liabilities183.46178.35157.93179.19-173.66
Long Term Debt931.68933.23926.86923.73-1,273.95
Provision for Risks Charges0.000.000.000.00-0.00
Deferred Tax Liabilities47.0443.5941.5088.87-74.45
Other Liabilities36.8738.5437.4434.74-28.61
Total Liabilities1,199.051,193.711,163.731,226.53-1,550.66
Non-Equity Reserves-0.000.000.00-0.00
Preferred Stock - Carrying Value0.000.000.000.00-0.00
Common Equity634.08615.06599.62586.12-161.65
Total Shareholders Equity634.08615.06599.62586.12-161.65
Accumulated Minority Interest-0.000.000.00-0.00
Total Equity634.08615.06599.62586.12-161.65
Total Liabilities & Stockholders Equity1,833.141,808.771,763.351,812.65-1,712.32
Book Value Per Share6.606.406.246.10-1.71
Tangible Book Value Per Share-2.21-2.42-2.58-2.73--7.34
Full-Time Employees---5,019--
Price to Book Ratio2.171.811.4171.61--
Return on Invested Capital0.460.180.11-1.90--1.75
Quick Ratio-1.421.391.26-0.99
Current Ratio1.521.421.391.26-0.99

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q12024Q4
Net Income7.182.751.72--7.69-
Depreciation14.8314.6814.04-12.90-
Other Funds (Non Cash)8.9213.9915.31-10.61-
Funds from Operations34.3833.5131.79-17.32-
Extraordinary Item-0.000.00-0.00-
Changes in Working Capital0.43-0.71-28.86--31.29-
Cash from Operating Activities34.8132.802.93--13.96-
Capital Expenditures-14.21-10.27-5.31--1.00-
Net Assets From Acquisitions-0.000.00-0.00-
Sale of Fixed Assets and Businesses0.160.000.04-0.28-
Purchase or Sale of Investments0.00-3.370.00-0.00-
Purchase of Investments0.00-3.370.00-0.00-
Sale Or Maturity of Investments-0.000.00-0.00-
Other Uses-0.000.00-0.00-
Other Sources-0.000.00-0.00-
Cash from Investing Activities-14.05-13.64-5.27--0.72-
Cash Dividends Paid-0.000.00-0.00-
Preferred Dividends (Cash Flow)-0.000.00-0.00-
Change in Capital Stock0.000.000.00-0.66-
Repurchase of Common Pref Stock-0.000.00-0.00-
Sale of Common Pref Stock0.000.000.00-0.66-
Proceedsfrom Stock Options0.000.000.00-0.66-
Issuance or Reduction of Debt, Net-1.25-0.69-5.26--4.81-
Change in Long Term Debt-1.25-0.26-5.35--4.81-
Issuance of Long Term Debt6.148.261.12-0.50-
Reduction of Long Term Debt-7.38-8.52-6.48--5.30-
Net Financing Active Other Cash Flow0.460.000.00-0.00-
Other Financing Activities Uses-0.620.000.00-0.00-
Cash from Financing Activities-0.45-0.69-5.26--4.15-
Net Change in Cash20.3118.48-7.60--18.83-
Free Cash Flow20.6023.13-2.38--14.96-

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.07%1.8M25.6M410.13K
2026-10-157.50%1.9M25.6M413.79K
2026-09-307.91%2.0M25.6M449.82K
2026-09-158.32%2.1M25.6M505.15K
2026-08-3110.20%2.6M25.6M589.33K
2026-08-149.95%2.5M25.6M723.28K
2026-07-3110.80%2.8M25.6M774.08K
2026-07-159.87%2.5M25.6M862.81K
2026-06-3011.05%2.8M25.6M913.04K
2026-06-1512.65%3.1M24.3M1.07M
2026-05-2913.16%3.4M25.6M1.05M
2026-05-1513.69%3.5M25.4M959.46K
2026-04-3013.29%3.2M24.2M886.24K
2026-04-1516.09%3.9M24.2M830.32K
2026-03-3113.29%3.2M24.2M834.66K
2026-03-133.01%0.7M23.8M603.60K
2026-02-272.45%0.6M23.8M722.92K
2026-02-132.82%0.7M23.8M773.21K
2026-01-300.91%0.9M94.2M810.90K
2026-01-151.03%1.0M94.2M966.56K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-10SEC
2026-08-14SCHEDULE 13GSEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-128-KCurrent report2026-08-12SEC
2026-06-308-KCurrent report2026-06-30SEC
2026-06-128-KCurrent report2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-14SEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-128-KCurrent report2026-05-12SEC
2026-04-28ARSAnnual report to security holders. 2025-12-31SEC
2026-04-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-28DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-10SEC
2026-04-098-KCurrent report2026-04-08SEC
2026-03-3010-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-268-KCurrent report2026-03-26SEC
2026-03-028-KCurrent report2026-03-02SEC
2026-02-274Statement of changes in beneficial ownership of securities2026-02-25SEC
2026-02-13SCHEDULE 13GSEC
2026-01-158-KCurrent report2026-01-12SEC
2026-01-154Statement of changes in beneficial ownership of securities2025-12-12SEC
2026-01-153Initial statement of beneficial ownership of securities2025-12-11SEC
2025-12-304Statement of changes in beneficial ownership of securities2025-12-12SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-05476.86K200
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BROWN ADVISORY INC6.01%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/3.59%
Think Investments LP2.66%
Jupiter Topco LLC2.24%
Brooklands Fund Management Ltd2.19%
BlackRock, Inc.1.46%
JPMORGAN CHASE & CO1.20%
VANGUARD CAPITAL MANAGEMENT LLC1.11%
ROYCE & ASSOCIATES LP1.03%
BRIGADE CAPITAL MANAGEMENT, LP0.89%

Funds

Fund% owned
Brown Advisory Small-Cap Fundamental Value Fund2.07%
MFS New Discovery Value Fund1.63%
Janus Henderson Triton Fund1.07%
Floating Rate Income Fund0.97%
Bridge Builder Small/Mid Cap Value Fund0.87%
AB Small Cap Growth Portfolio0.84%
VANGUARD TOTAL STOCK MARKET INDEX FUND0.79%
AB DISCOVERY GROWTH FUND, INC.0.71%
Janus Henderson Venture Fund0.64%
VANGUARD EXPLORER FUND0.61%

OakChart. LMRI. Cached 15 minutes.